-
Je něco špatně v tomto záznamu ?
Prebiotics Do Not Influence the Severity of Atopic Dermatitis in Infants: A Randomised Controlled Trial
J. Boženský, M. Hill, R. Zelenka, T. Skýba,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu klinické zkoušky, časopisecké články, randomizované kontrolované studie, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- antropometrie MeSH
- atopická dermatitida patologie prevence a kontrola MeSH
- dvojitá slepá metoda MeSH
- ekzém metabolismus patologie MeSH
- feces MeSH
- kojenec MeSH
- lidé MeSH
- náhražky mateřského mléka MeSH
- oligosacharidy terapeutické užití MeSH
- potravní doplňky MeSH
- prebiotika * MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
UNLABELLED: The objective was to evaluate the effects of a hypoallergenic (HA) formula supplemented with prebiotic galacto-oligosaccharides on the severity of atopic manifestations. A randomised clinical trial was conducted. The control group was infants, fed with hypoallergenic formula and without supplementation. The duration of the study was six months. The primary outcome of the study was a difference in the severity of atopic dermatitis measured using SCORAD (Scoring Atopic Dermatitis) criteria. Secondary outcomes were anthropometry (length, weight, and head circumference), together with the tolerance and incidence of infections. Both groups showed a decrease of average SCORAD values, but no statistically significant difference between the evaluated groups was observed. There were no statistically significant differences in anthropometry, or the tolerance or incidence of infections. Although there is no evidence, that consumption of a hypoallergenic infant formula enriched with prebiotic galacto-oligosaccharides had any effect on SCORAD, it was safe and well tolerated. TRIAL REGISTRATION: www.clinicaltrials.gov NCT 02077088.
Institute of Endocrinology Prague Czech Republic
Paediatrics Department Vitkovice Hospital Ostrava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020146
- 003
- CZ-PrNML
- 005
- 20160722115941.0
- 007
- ta
- 008
- 160722s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0142897 $2 doi
- 024 7_
- $a 10.1371/journal.pone.0142897 $2 doi
- 035 __
- $a (PubMed)26571488
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Boženský, Jan $u Paediatrics Department, Vitkovice Hospital, Ostrava, Czech Republic.
- 245 10
- $a Prebiotics Do Not Influence the Severity of Atopic Dermatitis in Infants: A Randomised Controlled Trial / $c J. Boženský, M. Hill, R. Zelenka, T. Skýba,
- 520 9_
- $a UNLABELLED: The objective was to evaluate the effects of a hypoallergenic (HA) formula supplemented with prebiotic galacto-oligosaccharides on the severity of atopic manifestations. A randomised clinical trial was conducted. The control group was infants, fed with hypoallergenic formula and without supplementation. The duration of the study was six months. The primary outcome of the study was a difference in the severity of atopic dermatitis measured using SCORAD (Scoring Atopic Dermatitis) criteria. Secondary outcomes were anthropometry (length, weight, and head circumference), together with the tolerance and incidence of infections. Both groups showed a decrease of average SCORAD values, but no statistically significant difference between the evaluated groups was observed. There were no statistically significant differences in anthropometry, or the tolerance or incidence of infections. Although there is no evidence, that consumption of a hypoallergenic infant formula enriched with prebiotic galacto-oligosaccharides had any effect on SCORAD, it was safe and well tolerated. TRIAL REGISTRATION: www.clinicaltrials.gov NCT 02077088.
- 650 _2
- $a antropometrie $7 D000886
- 650 _2
- $a atopická dermatitida $x patologie $x prevence a kontrola $7 D003876
- 650 _2
- $a potravní doplňky $7 D019587
- 650 _2
- $a dvojitá slepá metoda $7 D004311
- 650 _2
- $a ekzém $x metabolismus $x patologie $7 D004485
- 650 _2
- $a feces $7 D005243
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a náhražky mateřského mléka $7 D041943
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a oligosacharidy $x terapeutické užití $7 D009844
- 650 12
- $a prebiotika $7 D056692
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hill, Martin $u Institute of Endocrinology, Prague, Czech Republic.
- 700 1_
- $a Zelenka, Richard $u DMK Baby, Bremen, Germany.
- 700 1_
- $a Skýba, Tomáš $u Paediatrics Department, Vitkovice Hospital, Ostrava, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 11 (2015), s. e0142897
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26571488 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160722120155 $b ABA008
- 999 __
- $a ok $b bmc $g 1154816 $s 944674
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 10 $c 11 $d e0142897 $e 20151116 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20160722